0
     

Report Added
Report already added
Chronic Idiopathic Constipation Drugs Market - Global Outlook and Forecast 2022-2028

Chronic Idiopathic Constipation Drugs Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Chronic Idiopathic Constipation Drugs in global, including the following market information:

Global Chronic Idiopathic Constipation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Idiopathic Constipation Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Chronic Idiopathic Constipation Drugs companies in 2021 (%)
The global Chronic Idiopathic Constipation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Idiopathic Constipation Drugs include Pfizer, Glaxosmithkline, Roche Holding AG, Sanofi, Bayer AG, Merck, Eli Lilly, Allergens and Chugai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Idiopathic Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Chronic Idiopathic Constipation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Lubiprostone
Others
Global Chronic Idiopathic Constipation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Chronic Idiopathic Constipation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Idiopathic Constipation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Idiopathic Constipation Drugs revenues share in global market, 2021 (%)
Key companies Chronic Idiopathic Constipation Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Chronic Idiopathic Constipation Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Ferring International Center S.A
Synergy Pharmaceuticals
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Bausch Health
Daiichi Sankyo
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Theravance Biopharma Inc
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Chronic Idiopathic Constipation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Idiopathic Constipation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Idiopathic Constipation Drugs Overall Market Size
2.1 Global Chronic Idiopathic Constipation Drugs Market Size: 2021 VS 2028
2.2 Global Chronic Idiopathic Constipation Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chronic Idiopathic Constipation Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Chronic Idiopathic Constipation Drugs Players in Global Market
3.2 Top Global Chronic Idiopathic Constipation Drugs Companies Ranked by Revenue
3.3 Global Chronic Idiopathic Constipation Drugs Revenue by Companies
3.4 Global Chronic Idiopathic Constipation Drugs Sales by Companies
3.5 Global Chronic Idiopathic Constipation Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chronic Idiopathic Constipation Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chronic Idiopathic Constipation Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Idiopathic Constipation Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Idiopathic Constipation Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Idiopathic Constipation Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Idiopathic Constipation Drugs Market Size Markets, 2021 & 2028
4.1.2 Linaclotide
4.1.3 Lubiprostone
4.1.4 Others
4.2 By Type - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
4.2.2 By Type - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
4.2.3 By Type - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
4.3.2 By Type - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
4.3.3 By Type - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Chronic Idiopathic Constipation Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Chronic Idiopathic Constipation Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
5.2.2 By Application - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
5.2.3 By Application - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
5.3.2 By Application - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
5.3.3 By Application - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Chronic Idiopathic Constipation Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Chronic Idiopathic Constipation Drugs Market Size, 2021 & 2028
6.2 By Region - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
6.2.2 By Region - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
6.2.3 By Region - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
6.3.2 By Region - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
6.3.3 By Region - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.4.2 By Country - North America Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.4.3 US Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.4.4 Canada Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.4.5 Mexico Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.5.3 Germany Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.4 France Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.5 U.K. Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.6 Italy Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.7 Russia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.9 Benelux Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.6.3 China Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.4 Japan Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.5 South Korea Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.7 India Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.7.2 By Country - South America Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.7.3 Brazil Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.7.4 Argentina Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.8.3 Turkey Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.4 Israel Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.6 UAE Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Chronic Idiopathic Constipation Drugs Major Product Offerings
7.1.4 Pfizer Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Glaxosmithkline
7.2.1 Glaxosmithkline Corporate Summary
7.2.2 Glaxosmithkline Business Overview
7.2.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Major Product Offerings
7.2.4 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Glaxosmithkline Key News
7.3 Roche Holding AG
7.3.1 Roche Holding AG Corporate Summary
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Major Product Offerings
7.3.4 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Holding AG Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Chronic Idiopathic Constipation Drugs Major Product Offerings
7.4.4 Sanofi Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Chronic Idiopathic Constipation Drugs Major Product Offerings
7.5.4 Bayer AG Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Chronic Idiopathic Constipation Drugs Major Product Offerings
7.6.4 Merck Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Chronic Idiopathic Constipation Drugs Major Product Offerings
7.7.4 Eli Lilly Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Allergens
7.8.1 Allergens Corporate Summary
7.8.2 Allergens Business Overview
7.8.3 Allergens Chronic Idiopathic Constipation Drugs Major Product Offerings
7.8.4 Allergens Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Allergens Key News
7.9 Chugai Pharmaceutical
7.9.1 Chugai Pharmaceutical Corporate Summary
7.9.2 Chugai Pharmaceutical Business Overview
7.9.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Major Product Offerings
7.9.4 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Chugai Pharmaceutical Key News
7.10 Ferring International Center S.A
7.10.1 Ferring International Center S.A Corporate Summary
7.10.2 Ferring International Center S.A Business Overview
7.10.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Major Product Offerings
7.10.4 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Ferring International Center S.A Key News
7.11 Synergy Pharmaceuticals
7.11.1 Synergy Pharmaceuticals Corporate Summary
7.11.2 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Business Overview
7.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Major Product Offerings
7.11.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Synergy Pharmaceuticals Key News
7.12 Salix Pharmaceuticals Ltd
7.12.1 Salix Pharmaceuticals Ltd Corporate Summary
7.12.2 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Business Overview
7.12.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Major Product Offerings
7.12.4 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Salix Pharmaceuticals Ltd Key News
7.13 Sucampo Pharmaceuticals Inc
7.13.1 Sucampo Pharmaceuticals Inc Corporate Summary
7.13.2 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Overview
7.13.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.13.4 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Sucampo Pharmaceuticals Inc Key News
7.14 Ironwood Pharmaceuticals Inc
7.14.1 Ironwood Pharmaceuticals Inc Corporate Summary
7.14.2 Ironwood Pharmaceuticals Inc Business Overview
7.14.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.14.4 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Ironwood Pharmaceuticals Inc Key News
7.15 Bausch Health
7.15.1 Bausch Health Corporate Summary
7.15.2 Bausch Health Business Overview
7.15.3 Bausch Health Chronic Idiopathic Constipation Drugs Major Product Offerings
7.15.4 Bausch Health Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Bausch Health Key News
7.16 Daiichi Sankyo
7.16.1 Daiichi Sankyo Corporate Summary
7.16.2 Daiichi Sankyo Business Overview
7.16.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Major Product Offerings
7.16.4 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Daiichi Sankyo Key News
7.17 Cosmo Pharmaceuticals SA
7.17.1 Cosmo Pharmaceuticals SA Corporate Summary
7.17.2 Cosmo Pharmaceuticals SA Business Overview
7.17.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Major Product Offerings
7.17.4 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Cosmo Pharmaceuticals SA Key News
7.18 Progenics Pharmaceuticals Inc
7.18.1 Progenics Pharmaceuticals Inc Corporate Summary
7.18.2 Progenics Pharmaceuticals Inc Business Overview
7.18.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.18.4 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Progenics Pharmaceuticals Inc Key News
7.19 Theravance Biopharma Inc
7.19.1 Theravance Biopharma Inc Corporate Summary
7.19.2 Theravance Biopharma Inc Business Overview
7.19.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.19.4 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Theravance Biopharma Inc Key News
8 Global Chronic Idiopathic Constipation Drugs Production Capacity, Analysis
8.1 Global Chronic Idiopathic Constipation Drugs Production Capacity, 2017-2028
8.2 Chronic Idiopathic Constipation Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Idiopathic Constipation Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Idiopathic Constipation Drugs Supply Chain Analysis
10.1 Chronic Idiopathic Constipation Drugs Industry Value Chain
10.2 Chronic Idiopathic Constipation Drugs Upstream Market
10.3 Chronic Idiopathic Constipation Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Idiopathic Constipation Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Chronic Idiopathic Constipation Drugs in Global Market
Table 2. Top Chronic Idiopathic Constipation Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chronic Idiopathic Constipation Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chronic Idiopathic Constipation Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Chronic Idiopathic Constipation Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Chronic Idiopathic Constipation Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chronic Idiopathic Constipation Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Chronic Idiopathic Constipation Drugs Product Type
Table 9. List of Global Tier 1 Chronic Idiopathic Constipation Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Idiopathic Constipation Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2023-2028
Table 16. By Application – Global Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2023-2028
Table 21. By Region – Global Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chronic Idiopathic Constipation Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global Chronic Idiopathic Constipation Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Chronic Idiopathic Constipation Drugs Product Offerings
Table 48. Pfizer Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Glaxosmithkline Corporate Summary
Table 50. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Offerings
Table 51. Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Roche Holding AG Corporate Summary
Table 53. Roche Holding AG Chronic Idiopathic Constipation Drugs Product Offerings
Table 54. Roche Holding AG Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Chronic Idiopathic Constipation Drugs Product Offerings
Table 57. Sanofi Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Bayer AG Corporate Summary
Table 59. Bayer AG Chronic Idiopathic Constipation Drugs Product Offerings
Table 60. Bayer AG Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Chronic Idiopathic Constipation Drugs Product Offerings
Table 63. Merck Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly Chronic Idiopathic Constipation Drugs Product Offerings
Table 66. Eli Lilly Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Allergens Corporate Summary
Table 68. Allergens Chronic Idiopathic Constipation Drugs Product Offerings
Table 69. Allergens Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Chugai Pharmaceutical Corporate Summary
Table 71. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Offerings
Table 72. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Ferring International Center S.A Corporate Summary
Table 74. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Offerings
Table 75. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Synergy Pharmaceuticals Corporate Summary
Table 77. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Offerings
Table 78. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Salix Pharmaceuticals Ltd Corporate Summary
Table 80. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Offerings
Table 81. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Sucampo Pharmaceuticals Inc Corporate Summary
Table 83. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Offerings
Table 84. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Ironwood Pharmaceuticals Inc Corporate Summary
Table 86. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Offerings
Table 87. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Bausch Health Corporate Summary
Table 89. Bausch Health Chronic Idiopathic Constipation Drugs Product Offerings
Table 90. Bausch Health Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Daiichi Sankyo Corporate Summary
Table 92. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Offerings
Table 93. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Cosmo Pharmaceuticals SA Corporate Summary
Table 95. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Offerings
Table 96. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Progenics Pharmaceuticals Inc Corporate Summary
Table 98. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Offerings
Table 99. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Theravance Biopharma Inc Corporate Summary
Table 101. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Offerings
Table 102. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Chronic Idiopathic Constipation Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 104. Global Chronic Idiopathic Constipation Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Chronic Idiopathic Constipation Drugs Production by Region, 2017-2022 (K Pcs)
Table 106. Global Chronic Idiopathic Constipation Drugs Production by Region, 2023-2028 (K Pcs)
Table 107. Chronic Idiopathic Constipation Drugs Market Opportunities & Trends in Global Market
Table 108. Chronic Idiopathic Constipation Drugs Market Drivers in Global Market
Table 109. Chronic Idiopathic Constipation Drugs Market Restraints in Global Market
Table 110. Chronic Idiopathic Constipation Drugs Raw Materials
Table 111. Chronic Idiopathic Constipation Drugs Raw Materials Suppliers in Global Market
Table 112. Typical Chronic Idiopathic Constipation Drugs Downstream
Table 113. Chronic Idiopathic Constipation Drugs Downstream Clients in Global Market
Table 114. Chronic Idiopathic Constipation Drugs Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Chronic Idiopathic Constipation Drugs Segment by Type
Figure 2. Chronic Idiopathic Constipation Drugs Segment by Application
Figure 3. Global Chronic Idiopathic Constipation Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Idiopathic Constipation Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Chronic Idiopathic Constipation Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Idiopathic Constipation Drugs Revenue in 2021
Figure 9. By Type - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chronic Idiopathic Constipation Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chronic Idiopathic Constipation Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 19. US Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 24. Germany Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 33. China Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chronic Idiopathic Constipation Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chronic Idiopathic Constipation Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Chronic Idiopathic Constipation Drugs by Region, 2021 VS 2028
Figure 50. Chronic Idiopathic Constipation Drugs Industry Value Chain
Figure 51. Marketing Channels

Report Title: Chronic Idiopathic Constipation Drugs Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW